98%Metabolism HepaticHalf life 22 hoursExcretion ?Therapeutic considerationsPregnancy cat. ?Legal status ? Prescription onlyRoutes oralDoxazosin mesylate, doxazosin 4mg quinazoline compound sold by Pfizer under the brand names Cardura® and Carduran® , is an alpha blocker used to treat doxazosin 4mg blood pressure and benign.

methanoneIdentifiersCAS number 74191-85-8ATC code C02CA04PubChem 3157DrugBank APRD00474Chemical dataFormula C23H25N5O5Mol. mass 451.475 g/molPharmacokinetic dataBioavailability 65%Protein binding 98%Metabolism HepaticHalf life 22 hoursExcretion ?Therapeutic considerationsPregnancy cat. ?Legal status ? Prescription onlyRoutes oralDoxazosin mesylate, doxazosin 4mg quinazoline compound doxazosin 4mg by Pfizer under the brand names Cardura® and Carduran® , is an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the US FDA approved a sustained release form of doxazosin, to be marketed as Cardura® XL.It is an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the doxazosin 4mg FDA approved a doxazosin 4mg release form of doxazosin 4mg to be marketed as Cardura® XL.It is an doxazosin 4mg blocker used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the US doxazosin 4mg approved a doxazosin 4mg release form of doxazosin, to be marketed.

a sustained release form of doxazosin, to be doxazosin 4mg as Cardura® XL.It is an alpha blocker used to treat high.